Asma Jouini

Asma Jouini is a Senior Analyst in Market Access at Putnam PHMR since October 2022, specializing in market access strategy projects across therapeutic areas including oncology, dermatology, and rare diseases. Responsibilities include preparing submission packages for agencies such as NICE and HAS, developing objection handlers for payer negotiations, and conducting benchmark pricing analyses. Previous experience includes roles at Creativ-Ceutical, where Asma contributed to global value dossiers and strategic literature reviews, and at Clinique ophtalmologique de Tunis, focusing on quality management for Canadian accreditation. Academic credentials include a Leadership and Management in Health certificate from the University of Washington and an Engineer's degree in Cell Biology from Tunisia's private polytechnic central school. Notable publications include research on the IL-12 receptor gene in the Tunisian population.